Introduction To evaluate patient reported quality of life outcomes (QoL) following low‐dose‐
rate brachytherapy (LDR‐BT) and high‐dose‐rate brachytherapy (HDR‐BT) monotherapy …

PURPOSE Addition of a brachytherapy boost to external beam radiation therapy (EBRT)
reduces prostate cancer (PCa) recurrence at the expense of genitourinary (GU) toxicity …

Purpose High-dose-rate brachytherapy (HDR-BT) with external beam radiation therapy
(EBRT) is a common treatment option for locally advanced prostate cancer. Quality of life is …

Purpose To compare health-related quality of life (HRQOL) of high-dose-rate brachytherapy
(HDRB) versus low dose-rate brachytherapy (LDRB) for localized prostate cancer in a multi …

Purpose To compare health-related quality of life (QoL) in urinary, bowel, and sexual
domains after combined external beam radiation therapy (EBRT) and either low-dose rate …

Aims High dose rate (HDR) brachytherapy offers a highly conformal approach to
radiotherapy delivery, enabling dose escalation. We report our experience using a …

Background and purpose Little is known about the functional outcomes and health-related
quality of life (HRQoL) following external beam radiation therapy (EBRT) combined with a …

Purpose/Objective (s) This randomized phase III trial compared health related quality of life
(HRQOL) in urinary, bowel, and sexual domains in men with intermediate (IR) and high-risk …

Purpose There is little information in the literature on health-related quality of life (HRQOL)
changes due to high-dose-rate (HDR) brachytherapy monotherapy for prostate cancer …

Purpose High-dose-rate brachytherapy (HDR-BT) and external beam radiation therapy
(EBRT) are effective treatments for prostate cancer but cause genitourinary (GU) and …